Literature DB >> 25703736

Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy.

E S Gorell1, N Nguyen1, Z Siprashvili1, M P Marinkovich1,2, A T Lane1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25703736      PMCID： PMC4545744          DOI： 10.1111/bjd.13737

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  10 in total

Review 1.  Epidermolysis bullosa acquisita.

Authors:  Rishu Gupta; David T Woodley; Mei Chen
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

2.  Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation.

Authors:  A Hovnanian; A Rochat; C Bodemer; E Petit; C A Rivers; C Prost; S Fraitag; A M Christiano; J Uitto; M Lathrop; Y Barrandon; Y de Prost
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  The epitope for anti-type VII collagen monoclonal antibody (LH7:2) locates at the central region of the N-terminal non-collagenous domain of type VII collagen.

Authors:  T Tanaka; K Takahashi; F Furukawa; S Imamura
Journal:  Br J Dermatol       Date:  1994-10       Impact factor: 9.302

Review 4.  Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.

Authors:  Jo-David Fine; Leena Bruckner-Tuderman; Robin A J Eady; Eugene A Bauer; Johann W Bauer; Cristina Has; Adrian Heagerty; Helmut Hintner; Alain Hovnanian; Marcel F Jonkman; Irene Leigh; M Peter Marinkovich; Anna E Martinez; John A McGrath; Jemima E Mellerio; Celia Moss; Dedee F Murrell; Hiroshi Shimizu; Jouni Uitto; David Woodley; Giovanna Zambruno
Journal:  J Am Acad Dermatol       Date:  2014-03-29       Impact factor: 11.527

5.  Type VII collagen is required for Ras-driven human epidermal tumorigenesis.

Authors:  Susana Ortiz-Urda; John Garcia; Cheryl L Green; Lei Chen; Qun Lin; Dallas P Veitch; Lynn Y Sakai; Hyangkyu Lee; M Peter Marinkovich; Paul A Khavari
Journal:  Science       Date:  2005-03-18       Impact factor: 47.728

6.  Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa.

Authors:  V Pendaries; G Gasc; M Titeux; C Leroux; Z G Vitezica; J E Mejía; A Décha; P Loiseau; C Bodemer; C Prost-Squarcioni; A Hovnanian
Journal:  Gene Ther       Date:  2010-04-08       Impact factor: 5.250

7.  Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds.

Authors:  A F Falabella; I C Valencia; W H Eaglstein; L A Schachner
Journal:  Arch Dermatol       Date:  2000-10

8.  Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa.

Authors:  Dimitra Kiritsi; Marta Garcia; Renske Brander; Cristina Has; Rowdy Meijer; Maria Jose Escámez; Jürgen Kohlhase; Peter C van den Akker; Hans Scheffer; Marcel F Jonkman; Marcela Del Rio; Leena Bruckner-Tuderman; Anna M G Pasmooij
Journal:  J Invest Dermatol       Date:  2014-02-27       Impact factor: 8.551

9.  Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa.

Authors:  Marilina Tampoia; Domenico Bonamonte; Angela Filoni; Lucrezia Garofalo; Maria Grazia Morgese; Luigia Brunetti; Chiara Di Giorgio; Giuseppina Annicchiarico
Journal:  Orphanet J Rare Dis       Date:  2013-09-04       Impact factor: 4.123

10.  De novo anti-type VII collagen antibodies in patients with recessive dystrophic epidermolysis bullosa.

Authors:  David T Woodley; Jon Cogan; Xinyi Wang; Yingping Hou; Cyrus Haghighian; Gail Kudo; Douglas R Keene; Mei Chen
Journal:  J Invest Dermatol       Date:  2013-11-08       Impact factor: 8.551
  10 in total
  7 in total

1.  Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.

Authors:  David T Woodley; Jon Cogan; Yingping Hou; Chao Lyu; M Peter Marinkovich; Douglas Keene; Mei Chen
Journal:  J Clin Invest       Date:  2017-07-10       Impact factor: 14.808

2.  Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.

Authors:  Shaundra Eichstadt; Melissa Barriga; Anusha Ponakala; Claudia Teng; Ngon T Nguyen; Zurab Siprashvili; Jaron Nazaroff; Emily S Gorell; Albert S Chiou; Lisa Taylor; Phuong Khuu; Douglas R Keene; Kerri Rieger; Rohit K Khosla; Louise K Furukawa; H Peter Lorenz; M Peter Marinkovich; Jean Y Tang
Journal:  JCI Insight       Date:  2019-10-03

Review 3.  Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know.

Authors:  Ruby Khoury; Sharon Sauter; Melinda Butsch Kovacic; Adam S Nelson; Kasiani C Myers; Parinda A Mehta; Stella M Davies; Susanne I Wells
Journal:  Viruses       Date:  2018-01-20       Impact factor: 5.048

Review 4.  A rare case of skin blistering and esophageal stenosis in the course of epidermolysis bullosa - case report and literature review.

Authors:  Agata Michalak; Halina Cichoż-Lach; Beata Prozorow-Król; Leszek Buk; Monika Dzida
Journal:  BMC Gastroenterol       Date:  2018-04-13       Impact factor: 3.067

5.  Signatures of Dermal Fibroblasts from RDEB Pediatric Patients.

Authors:  Arkadii K Beilin; Nadezhda A Evtushenko; Daniil K Lukyanov; Nikolay N Murashkin; Eduard T Ambarchian; Alexander A Pushkov; Kirill V Savostyanov; Andrey P Fisenko; Olga S Rogovaya; Andrey V Vasiliev; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

6.  In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.

Authors:  Irina Gurevich; Pooja Agarwal; PeiPei Zhang; John A Dolorito; Stacie Oliver; Henry Liu; Nicholas Reitze; Nikhil Sarma; Isin Sinem Bagci; Kunju Sridhar; Visesha Kakarla; Vamsi K Yenamandra; Mark O'Malley; Marco Prisco; Sara F Tufa; Douglas R Keene; Andrew P South; Suma M Krishnan; M Peter Marinkovich
Journal:  Nat Med       Date:  2022-03-28       Impact factor: 87.241

7.  Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.

Authors:  Jodi Y So; Jaron Nazaroff; Chinonso V Iwummadu; Nicki Harris; Emily S Gorell; Shivali Fulchand; Irene Bailey; Daniel McCarthy; Zurab Siprashvili; M Peter Marinkovich; Jean Y Tang; Albert S Chiou
Journal:  Orphanet J Rare Dis       Date:  2022-10-17       Impact factor: 4.303
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.